| 1 |
29731965 | TP53 and OSBPL10 alterations in diffuse large B-cell lymphoma: prognostic markers identified via exome analysis of cases with extreme prognosis. | 2018 Apr 13 |
2 |
| 2 |
28791403 | Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas. | 2017 Oct |
1 |
| 3 |
22955915 | Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. | 2012 Nov 8 |
1 |
| 4 |
20435884 | Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study. | 2010 Aug 19 |
1 |
| 5 |
21290342 | Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia. | 2010 |
3 |
| 6 |
7563172 | Accumulation of p53 protein as a possible predictor of response to adjuvant combination chemotherapy with cyclophosphamide, methotrexate, fluorouracil, and prednisone for breast cancer. | 1995 Aug 16 |
1 |